Contract Research Organisations (CROs) Market Report 2022-2032
Forecasts by Services (Preclinical, Clinical (Phase I, Phase II, Phase III, Phase IV), Laboratory Services, Consulting Services, Data Management Services), by Company Size (Large Pharma & Biotech Companies, Mid-sized Pharma & Biotech Companies, Small Pharma & Biotech Companies), by Drug Type (Small Molecules, Large Molecules), by Therapeutic Area (Oncology, CNS, Cardiology, Infectious, Metabolic, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Contract Research Organizations (CROs) Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth One of the main factors fuelling the demand for generics is the pressure to lower the rising healthcare expenses. The market entry of various less expensive generic substitutes was made possible by patent expiration. Since generic manufacturing firms contract with CDMOs for over 80% of their manufacturing, patent expiration is a positive indication of a booming market. Some of the well-known medications whose patents ran out in 2021 include Lucentis from Roche, Adasuve from Galen, Performist from Mylan, Northera from Lundbeck, and Narcan from Emergent BioSolutions.
Supply Chain Disruptions Likely to Hamper Market The pharmaceutical sector is susceptible to supply chain disruptions caused by natural disasters in a particular location. High inventory levels alone are insufficient to protect against supply chain shocks since disruptions are becoming more frequent, for instance, the COVID-19 pandemic two years ago and the recent monkeypox outbreak. Anticipatory planning is necessary for managing supply chain interruptions, and several of the large CROs are already highly proficient at foreseeing and resolving shortages. Smaller CROs, however, are more likely to face supply chain disruptions.
The larger CROs have the financial capacity to keep large inventory in case of future financial constraints. The smaller CROs lack the infrastructure and resources necessary to manage supply chains and prevent shortages. Despite difficulties including managing sponsors, workforce scarcity, and market consolidation, the demand for outsourced R&D services will continue to support the CRO business.
What Questions Should You Ask before Buying a Market Research Report? • How is the Contract Research Organizations (CROs) market evolving? • What is driving and restraining the Contract Research Organizations (CROs) market? • How will each Contract Research Organizations (CROs) submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032? • How will the market shares for each Contract Research Organizations (CROs) submarket develop from 2022 to 2032? • What will be the main driver for the overall market from 2022 to 2032? • Will leading Contract Research Organizations (CROs) markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032? • Who are the leading players and what are their prospects over the forecast period? • What are the Contract Research Organizations (CROs) projects for these leading companies? • How will the industry evolve during the period between 2020 and 2032? What are the implications of Contract Research Organizations (CROs) projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the Contract Research Organizations (CROs) market? • Where is the Contract Research Organizations (CROs) market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Contract Research Organizations (CROs) market today, and over the next 10 years: • Our 305-page report provides 116 tables and 180 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Contract Research Organizations (CROs) market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
To access the data contained in this document, please email contactus@visiongain.com
Forecasts to 2032 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Contract Research Organizations (CROs) prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Services Outlook • Preclinical • Clinical – Phase I – Phase II – Phase III – Phase IV • Laboratory Services • Consulting Services • Data Management Services
Company Size Outlook • Large Pharma & Biotech Companies • Mid-sized Pharma & Biotech Companies • Small Pharma & Biotech Companies
Drug Type Outlook • Small Molecules • Large Molecules
Therapeutic Area Outlook • Oncology • CNS • Cardiology • Infectious • Metabolic • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America • U.S. • Canada
Europe • Germany • UK • France • Italy • Spain • Rest of Europe
Asia Pacific • China • Japan • India • Australia • South Korea • Rest of Asia Pacific
Latin America • Brazil • Mexio • Rest of Latin America
The report also includes profiles and for some of the leading companies in the Contract Research Organizations (CROs) Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • Charles River Laboratories • Clinipace • CMIC HOLDING Co., LTD. • EPS Corporation • ICON plc • IQVIA HOLDINGS INC. • Labcorp Drug Development • MedPace • Parexel • PPD (Thermofisher Scientific Inc.) • Syneos Health • Worldwide Clinical Trials • Wuxi AppTec
Overall world revenue for Contract Research Organizations (CROs) Market, 2022 to 2032 in terms of value the market will surpass US$62 billion in 2022, our work calculates. We predict strong revenue growth through to 2032.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Contract Research Organizations (CROs) Market, 2022 to 2032 report help you? In summary, our 300+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Contract Research Organizations (CROs) Market, 2022 to 2032 Market, with forecasts for services, company size, drug type, and therapeutic area each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 13 key national markets – See forecasts for the Contract Research Organizations (CROs) Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 13 of the major companies involved in the Contract Research Organizations (CROs) Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Contract Research Organizations (CROs) Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
Buy our report today Contract Research Organisations (CROs) Market Report 2022-2032: Forecasts by Services (Preclinical, Clinical (Phase I, Phase II, Phase III, Phase IV), Laboratory Services, Consulting Services, Data Management Services), by Company Size (Large Pharma & Biotech Companies, Mid-sized Pharma & Biotech Companies, Small Pharma & Biotech Companies), by Drug Type (Small Molecules, Large Molecules), by Therapeutic Area (Oncology, CNS, Cardiology, Infectious, Metabolic, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview 1.1 Objectives of the Study 1.2 Introduction to Contract Research Organizations (CROs) Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered By This Analytical Report Include: 1.6 Who is This Report For? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.7.3.1 Primary Research 1.7.3.2 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Market Overview 3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 Rising Demand for Clinical Trials Globally 3.2.1.2 Growing Disease Burden Globally to Fuel CROs Market Growth 3.2.1.3 Rising R&D Investments by Pharmaceutical and Biotech Companies to Boost CROs Market Growth 3.2.1.4 Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth 3.2.2 Market Restraining Factors 3.2.2.1 Intellectual Property Issues May Hamper CROs Industry Growth 3.2.2.2 Shortage of Skilled Labour Post COVID-19 Hampering CRO Industry 3.2.3 Market Opportunities 3.2.3.1 Applications of Artificial Intelligence Could Lead to Faster, Safer and Significantly Less Expensive Clinical Trials 3.2.3.2 Increasing Demand for Biological Therapies to Offer Lucrative Growth Prospects for CROs 3.2.3.3 Growth in Nuclear Medicine Sector 3.3 COVID-19 Impact Analysis 3.4 Porter’s Five Forces Analysis 3.4.1.1 Competitive Rivalry: High 3.4.1.2 Threat of New Entrants: Low to Medium 3.4.1.3 Threat of Substitutes: Low to Medium 3.4.1.4 Bargaining Power of Buyers: Medium to High 3.4.1.5 Bargaining Power of Suppliers: Medium to High 3.5 PEST Analysis 3.6 How has the Pharmaceutical Industry Adapted Amidst the Pandemic? 3.7 Why are CROs Adopting Mergers & Acquisitions? 3.8 Mergers & Acquisitions Volume and Public Market Valuations
4 Global Contract Research Organizations (CROs) Market Analysis by Services 4.1 Key Findings 4.2 Services Segment Growth Prospects 4.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Services 4.4 Preclinical 4.4.1 Market Forecast by Region, 2022-2032 (US$ Mn) 4.4.2 Market Share by Region, 2022 & 2032 (%) 4.5 Clinical 4.5.1 Market Forecast by Region, 2022-2032 (US$ Mn) 4.5.2 Market Share by Region, 2022 & 2032 (%) 4.6 Laboratory Services 4.6.1 Market Forecast by Region, 2022-2032 (US$ Mn) 4.6.2 Market Share by Region, 2022 & 2032 (%) 4.7 Consulting Services 4.7.1 Market Forecast by Region, 2022-2032 (US$ Mn) 4.7.2 Market Share by Region, 2022 & 2032 (%) 4.8 Data Management Services 4.8.1 Market Forecast by Region, 2022-2032 (US$ Mn) 4.8.2 Market Share by Region, 2022 & 2032 (%)
5 Global Contract Research Organizations (CROs) Market Analysis by Company Size 5.1 Key Findings 5.2 Company Size Segment Growth Prospects 5.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Company Size 5.4 Large Pharma & Biotech Companies 5.4.1 Market Forecast by Region, 2022-2032 (US$ Mn) 5.4.2 Market Share by Region, 2022 & 2032 (%) 5.5 Mid-sized Pharma & Biotech Companies 5.5.1 Market Forecast by Region, 2022-2032 (US$ Mn) 5.5.2 Market Share by Region, 2022 & 2032 (%) 5.6 Small Pharma & Biotech Companies 5.6.1 Market Forecast by Region, 2022-2032 (US$ Mn) 5.6.2 Market Share by Region, 2022 & 2032 (%)
6 Global Contract Research Organizations (CROs) Market Analysis by Drug Type 6.1 Key Findings 6.2 Drug Type Segment Growth Prospects 6.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Drug Type 6.4 Small Molecules 6.4.1 Market Forecast by Region, 2022-2032 (US$ Mn) 6.4.2 Market Share by Region, 2022 & 2032 (%) 6.5 Large Molecules 6.5.1 Market Forecast by Region, 2022-2032 (US$ Mn) 6.5.2 Market Share by Region, 2022 & 2032 (%)
7 Global Contract Research Organizations (CROs) Market Analysis by Therapeutic Area 7.1 Key Findings 7.2 Therapeutic Area Segment Growth Prospects 7.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Therapeutic Area 7.4 Oncology 7.4.1 Market Forecast by Region, 2022-2032 (US$ Mn) 7.4.2 Market Share by Region, 2022 & 2032 (%) 7.5 CNS 7.5.1 Market Forecast by Region, 2022-2032 (US$ Mn) 7.5.2 Market Share by Region, 2022 & 2032 (%) 7.6 Cardiology 7.6.1 Market Forecast by Region, 2022-2032 (US$ Mn) 7.6.2 Market Share by Region, 2022 & 2032 (%) 7.7 Infectious 7.7.1 Market Forecast by Region, 2022-2032 (US$ Mn) 7.7.2 Market Share by Region, 2022 & 2032 (%) 7.8 Metabolic 7.8.1 Market Forecast by Region, 2022-2032 (US$ Mn) 7.8.2 Market Share by Region, 2022 & 2032 (%) 7.9 Others 7.9.1 Market Forecast by Region, 2022-2032 (US$ Mn) 7.9.2 Market Share by Region, 2022 & 2032 (%)
8 Global Contract Research Organizations (CROs) Market Analysis by Region 8.1 Key Findings 8.2 Regional Market Size Estimation and Forecast 8.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
9 North America Contract Research Organizations (CROs) Market Analysis 9.1 Key Findings 9.2 North America Contract Research Organizations (CROs) Market Attractiveness Index 9.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn) 9.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn) 9.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn) 9.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn) 9.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn) 9.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn) 9.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn) 9.9 U.S. CROs Market Analysis 9.10 Canada CROs Market Analysis
10 Europe Contract Research Organizations (CROs) Market Analysis 10.1 Key Findings 10.2 Europe Contract Research Organizations (CROs) Market Attractiveness Index 10.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn) 10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn) 10.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn) 10.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn) 10.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn) 10.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn) 10.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn) 10.9 Germany CROs Market Analysis 10.10 UK CROs Market Analysis 10.11 France CROs Market Analysis 10.12 Italy CROs Market Analysis 10.13 Spain CROs Market Analysis 10.14 Rest of Europe CROs Market Analysis
11 Asia Pacific Contract Research Organizations (CROs) Market Analysis 11.1 Key Findings 11.2 Asia Pacific Contract Research Organizations (CROs) Market Attractiveness Index 11.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn) 11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn) 11.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn) 11.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn) 11.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn) 11.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn) 11.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn) 11.9 Japan CROs Market Analysis 11.10 China CROs Market Analysis 11.11 India CROs Market Analysis 11.12 Australia CROs Market Analysis 11.13 South Korea CROs Market Analysis 11.14 Rest of Asia Pacific CROs Market Analysis
12 Latin America Contract Research Organizations (CROs) Market Analysis 12.1 Key Findings 12.2 Latin America Contract Research Organizations (CROs) Market Attractiveness Index 12.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn) 12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn) 12.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn) 12.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn) 12.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn) 12.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn) 12.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn) 12.9 Brazil CROs Market Analysis 12.10 Mexico CROs Market Analysis 12.11 Rest of Latin America
13 MEA Contract Research Organizations (CROs) Market Analysis 13.1 Key Findings 13.2 MEA Contract Research Organizations (CROs) Market Attractiveness Index 13.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn) 13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn) 13.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn) 13.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn) 13.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn) 13.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn) 13.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn) 13.9 GCC CROs Market Analysis 13.10 South Africa CROs Market Analysis 13.11 Rest of MEA CROs Market Analysis
14 Company Profiles 14.1 Competitive Landscape, 2021 14.2 Charles River Laboratories 14.2.1 Company Snapshot 14.2.2 Company Overview 14.2.3 Financial Analysis 14.2.3.1 Net Revenue, 2016-2021 14.2.3.2 Regional Market Shares, 2021 14.2.3.3 Gross Profit, 2016-2021 14.2.4 Product Benchmarking 14.2.5 Strategic Outlook 14.3 Clinipace 14.3.1 Company Snapshot 14.3.2 Company Overview 14.3.3 Product Benchmarking 14.4 CMIC HOLDING Co., LTD. 14.4.1 Company Snapshot 14.4.2 Company Overview 14.4.3 Financial Analysis 14.4.3.1 Net Revenue, 2016-2021 14.4.4 Product Benchmarking 14.4.5 Strategic Outlook 14.5 EPS Corporation 14.5.1 Company Snapshot 14.5.2 Company Overview 14.5.3 Financial Analysis 14.5.3.1 Net Revenue, 2016-2021 14.5.4 Product Benchmarking 14.6 ICON plc 14.6.1 Company Snapshot 14.6.2 Company Overview 14.6.3 Financial Analysis 14.6.3.1 Net Revenue, 2016-2021 14.6.3.2 Gross Profit, 2016-2021 14.6.4 Product Benchmarking 14.6.5 Strategic Outlook 14.7 IQVIA HOLDINGS INC. 14.7.1 Company Snapshot 14.7.2 Company Overview 14.7.3 Financial Analysis 14.7.3.1 Net Revenue, 2016-2021 14.7.3.2 Regional Market Shares, 2021 14.7.3.3 Gross Profit, 2016-2021 14.7.4 Product Benchmarking 14.7.5 Strategic Outlook 14.8 Labcorp Drug Development 14.8.1 Company Snapshot 14.8.2 Company Overview 14.8.3 Financial Analysis 14.8.3.1 Net Revenue, 2016-2021 14.8.3.2 Regional Market Shares, 2021 14.8.3.3 Gross Profit, 2016-2021 14.8.4 Product Benchmarking 14.8.5 Strategic Outlook 14.9 MedPace 14.9.1 Company Snapshot 14.9.2 Company Overview 14.9.3 Financial Analysis 14.9.3.1 Net Revenue, 2016-2021 14.9.3.2 Gross Profit, 2016-2021 14.9.4 Product Benchmarking 14.10 Parexel 14.10.1 Company Snapshot 14.10.2 Company Overview 14.10.3 Product Benchmarking 14.10.4 Strategic Outlook 14.11 PPD (ThermoFisher Scientific Inc.) 14.11.1 Company Snapshot 14.11.2 Company Overview 14.11.3 Financial Analysis 14.11.3.1 Net Revenue, 2016-2021 14.11.3.2 Regional Market Shares, 2021 14.11.3.3 Gross Profit, 2016-2021 14.11.3.4 R&D, 2016-2021 14.11.4 Product Benchmarking 14.11.5 Strategic Outlook 14.12 Syneos Health 14.12.1 Company Snapshot 14.12.2 Company Overview 14.12.3 Financial Analysis 14.12.3.1 Net Revenue, 2016-2021 14.12.3.2 Regional Market Shares, 2021 14.12.3.3 Gross Profit, 2016-2021 14.12.4 Product Benchmarking 14.12.5 Strategic Outlook 14.13 Worldwide Clinical Trials 14.13.1 Company Snapshot 14.13.2 Company Overview 14.13.3 Product Benchmarking 14.13.4 Strategic Outlook 14.14 Wuxi AppTec 14.14.1 Company Snapshot 14.14.2 Company Overview 14.14.3 Financial Analysis 14.14.3.1 Net Revenue, 2016-2021 14.14.3.2 Regional Market Shares, 2021 14.14.3.3 Gross Profit, 2016-2020 14.14.4 Product Benchmarking 14.14.5 Strategic Outlook
15 Conclusion and Recommendations 15.1 Concluding Remarks from Visiongain 15.2 Recommendations for Market Players
List of Tables Table 1 Global Contract Research Organizations (CROs) Market Snapshot, 2022 & 2032 (US$ million, CAGR %) Table 2 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery Table 3 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery Table 4 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery Table 5 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery Table 6 Global Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%) Table 7 Preclinical Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 8 Preclinical Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 9 Laboratory Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 10 Consulting Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 11 Data Management Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 12 Global Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%) Table 13 Large Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 14 Mid-sized Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 15 Small Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 16 Global Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%) Table 17 Small Molecules Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 18 Large Molecules Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 19 Global Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%) Table 20 Oncology Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 21 CNS Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 22 Cardiology Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 23 Infectious Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 24 Metabolic Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 25 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 26 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%) Table 27 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery Table 28 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery Table 29 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery Table 30 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery Table 31 North America Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%) Table 32 North America Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%) Table 33 North America Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%) Table 34 North America Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%) Table 35 North America Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%) Table 36 North America Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%) Table 37 U.S. Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 38 Canada Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 39 Europe Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%) Table 40 Europe Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%) Table 41 Europe Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%) Table 42 Europe Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%) Table 43 Europe Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%) Table 44 Europe Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%) Table 45 Germany Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 46 UK Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 47 France Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 48 Italy Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 49 Spain Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 50 Rest of Europe Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 51 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%) Table 52 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%) Table 53 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%) Table 54 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%) Table 55 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%) Table 56 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%) Table 57 Japan Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 58 China Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 59 India Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 60 Australia Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 61 South Korea Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 62 Rest of Asia Pacific Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 63 Latin America Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%) Table 64 Latin America Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%) Table 65 Latin America Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%) Table 66 Latin America Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%) Table 67 Latin America Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%) Table 68 Latin America Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%) Table 69 Brazil Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 70 Mexico Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 71 Rest of Latin America Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 72 MEA Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%) Table 73 MEA Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%) Table 74 MEA Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%) Table 75 MEA Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%) Table 76 MEA Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%) Table 77 MEA Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%) Table 78 GCC Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 79 South Africa Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 80 Rest of MEA Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%) Table 81 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 82 Charles River Laboratories: Product Benchmarking Table 83 Charles River Laboratories: Strategic Outlook Table 84 Clinipace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 85 Clinipace: Product Benchmarking Table 86 CMIC HOLDING Co., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 87 CMIC HOLDING Co., LTD.: Product Benchmarking Table 88 CMIC HOLDING Co., LTD.: Strategic Outlook Table 89 EPS Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 90 EPS Corporation: Product Benchmarking Table 91 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 92 ICON plc: Product Benchmarking Table 93 ICON plc: Strategic Outlook Table 94 IQVIA HOLDINGS INC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 95 IQVIA HOLDINGS INC.: Product Benchmarking Table 96 IQVIA HOLDINGS INC.: Strategic Outlook Table 97 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 98 Labcorp Drug Development: Product Benchmarking Table 99 Labcorp Drug Development: Strategic Outlook Table 100 MedPace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 101 MedPace: Product Benchmarking Table 102 Parexel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 103 Parexel: Product Benchmarking Table 104 Parexel: Strategic Outlook Table 105 PPD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 106 PPD: Product Benchmarking Table 107 PPD: Strategic Outlook Table 108 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 109 Syneos Health: Product Benchmarking Table 110 Syneos Health: Strategic Outlook Table 111 Worldwide Clinical Trials: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 112 Worldwide Clinical Trials: Product Benchmarking Table 113 Worldwide Clinical Trials: Strategic Outlook Table 114 Wuxi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 115 Wuxi AppTec: Product Benchmarking Table 116 Wuxi AppTec: Strategic Outlook
List of Figures Figure 1 Global Contract Research Organizations (CROs) Market Segmentation Figure 2 Global Contract Research Organizations (CROs) Market by Services: Market Attractiveness Index Figure 3 Global Contract Research Organizations (CROs) Market by Company Size: Market Attractiveness Index Figure 4 Global Contract Research Organizations (CROs) Market by Drug Type: Market Attractiveness Index Figure 5 Global Contract Research Organizations (CROs) Market by Therapeutic Area: Market Attractiveness Index Figure 6 Global Contract Research Organizations (CROs) Market Attractiveness Index by Region Figure 7 Global Contract Research Organizations (CROs) Market: Market Dynamics Figure 8 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Figure 9 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Figure 10 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Figure 11 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Figure 12 Porter’s Five Forces Analysis Figure 13 PEST Analysis Figure 14 Deal Volume, 2017-2021 Figure 15 Global Contract Research Organizations (CROs) Market Attractiveness Index by Services Figure 16 Global Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million) Figure 17 Global Contract Research Organizations (CROs) Market Share Forecast by Services, 2022, 2027, 2032 (%) Figure 18 Preclinical Market Forecast by Region, 2022-2032 (US$ million) Figure 19 Preclinical Market Share Forecast by Region, 2022 & 2032 (%) Figure 20 Clinical Market Forecast by Region, 2022-2032 (US$ million) Figure 21 Clinical Market Share Forecast by Region, 2022 & 2032 (%) Figure 22 Laboratory Services Market Forecast by Region, 2022-2032 (US$ million) Figure 23 Laboratory Services Market Share Forecast by Region, 2022 & 2032 (%) Figure 24 Consulting Services Market Forecast by Region, 2022-2032 (US$ million) Figure 25 Consulting Services Market Share Forecast by Region, 2022 & 2032 (%) Figure 26 Data Management Services Market Forecast by Region, 2022-2032 (US$ million) Figure 27 Data Management Services Market Share Forecast by Region, 2022 & 2032 (%) Figure 28 Global Contract Research Organizations (CROs) Market Attractiveness Index by Company Size Figure 29 Global Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 30 Global Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022, 2027, 2032 (%) Figure 31 Large Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million) Figure 32 Large Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%) Figure 33 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million) Figure 34 Mid-sized Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%) Figure 35 Small Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million) Figure 36 Small Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%) Figure 37 Global Contract Research Organizations (CROs) Market Attractiveness Index by Drug Type Figure 38 Global Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million) Figure 39 Global Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022, 2027, 2032 (%) Figure 40 Small Molecules Market Forecast by Region, 2022-2032 (US$ million) Figure 41 Small Molecules Market Share Forecast by Region, 2022 & 2032 (%) Figure 42 Large Molecules Market Forecast by Region, 2022-2032 (US$ million) Figure 43 Large Molecules Market Share Forecast by Region, 2022 & 2032 (%) Figure 44 Global Contract Research Organizations (CROs) Market Attractiveness Index by Therapeutic Area Figure 45 Global Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million) Figure 46 Global Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022, 2027, 2032 (%) Figure 47 Oncology Market Forecast by Region, 2022-2032 (US$ million) Figure 48 Oncology Market Share Forecast by Region, 2022 & 2032 (%) Figure 49 CNS Market Forecast by Region, 2022-2032 (US$ million) Figure 50 CNS Market Share Forecast by Region, 2022 & 2032 (%) Figure 51 Cardiology Market Forecast by Region, 2022-2032 (US$ million) Figure 52 Cardiology Market Share Forecast by Region, 2022 & 2032 (%) Figure 53 Infectious Market Forecast by Region, 2022-2032 (US$ million) Figure 54 Infectious Market Share Forecast by Region, 2022 & 2032 (%) Figure 55 Metabolic Market Forecast by Region, 2022-2032 (US$ million) Figure 56 Metabolic Market Share Forecast by Region, 2022 & 2032 (%) Figure 57 Others Market Forecast by Region, 2022-2032 (US$ million) Figure 58 Others Market Share Forecast by Region, 2022 & 2032 (%) Figure 59 Global Contract Research Organizations (CROs) Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR %) Figure 60 Global Contract Research Organizations (CROs) Market Share Forecast by Region 2022, 2027, 2032(%) Figure 61 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) Figure 62 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Figure 63 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Figure 64 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Figure 65 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Figure 66 North America Contract Research Organizations (CROs) Market Attractiveness Index Figure 67 North America Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million) Figure 68 North America Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million) Figure 69 North America Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%) Figure 70 North America Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million) Figure 71 North America Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%) Figure 72 North America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 73 North America Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%) Figure 74 North America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 75 North America Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%) Figure 76 North America Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million) Figure 77 North America Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%) Figure 78 North America Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million) Figure 79 North America Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%) Figure 80 U.S. Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 81 Canada Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 82 Europe Contract Research Organizations (CROs) Market Attractiveness Index Figure 83 Europe Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million) Figure 84 Europe Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million) Figure 85 Europe Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%) Figure 86 Europe Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million) Figure 87 Europe Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%) Figure 88 Europe Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 89 Europe Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%) Figure 90 Europe Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 91 Europe Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%) Figure 92 Europe Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million) Figure 93 Europe Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%) Figure 94 Europe Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million) Figure 95 Europe Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%) Figure 96 Germany Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 97 UK Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 98 France Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 99 Italy Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 100 Spain Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 101 Rest of Europe Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 102 Asia Pacific Contract Research Organizations (CROs) Market Attractiveness Index Figure 103 Asia Pacific Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million) Figure 104 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million) Figure 105 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%) Figure 106 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million) Figure 107 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%) Figure 108 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Clinical Phase, 2022-2032 (US$ million) Figure 109 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%) Figure 110 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 111 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%) Figure 112 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million) Figure 113 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%) Figure 114 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million) Figure 115 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%) Figure 116 Japan Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 117 China Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 118 India Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 119 Australia Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 120 South Korea Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 121 Rest of Asia Pacific Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 122 Latin America Contract Research Organizations (CROs) Market Attractiveness Index Figure 123 Latin America Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million) Figure 124 Latin America Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million) Figure 125 Latin America Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%) Figure 126 Latin America Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million) Figure 127 Latin America Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%) Figure 128 Latin America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 129 Latin America Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%) Figure 130 Latin America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 131 Latin America Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%) Figure 132 Latin America Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million) Figure 133 Latin America Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%) Figure 134 Latin America Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million) Figure 135 Latin America Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%) Figure 136 Brazil Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 137 Mexico Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 138 Rest of Latin America Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 139 MEA Contract Research Organizations (CROs) Market Attractiveness Index Figure 140 MEA Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million) Figure 141 MEA Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million) Figure 142 MEA Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%) Figure 143 MEA Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million) Figure 144 MEA Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%) Figure 145 MEA Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 146 MEA Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%) Figure 147 MEA Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million) Figure 148 MEA Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%) Figure 149 MEA Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million) Figure 150 MEA Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%) Figure 151 MEA Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million) Figure 152 MEA Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%) Figure 153 GCC Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 154 South Africa Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 155 Rest of MEA Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million) Figure 156 Global Contract Research Organizations (CROs) Market: Company Share/Ranking, 2021 Figure 157 Charles River Laboratories: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 158 Charles River Laboratories: Regional Market Shares (%), 2021 Figure 159 Charles River Laboratories: Gross Profit, 2016-2021 (US$ million, AGR %) Figure 160 CMIC HOLDING Co., LTD.: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 161 EPS Corporation: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 162 ICON plc: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 163 ICON plc: Gross Profit, 2016-2021 (US$ million, AGR %) Figure 164 IQVIA HOLDINGS INC.: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 165 IQVIA HOLDINGS INC.: Regional Market Shares (%), 2021 Figure 166 IQVIA HOLDINGS INC.: Gross Profit, 2016-2021 (US$ million, AGR %) Figure 167 Labcorp Drug Development: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 168 Labcorp Drug Development: Regional Market Shares (%), 2021 Figure 169 Labcorp Drug Development: Gross Profit, 2016-2021 (US$ million, AGR %) Figure 170 MedPace: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 171 MedPace: Gross Profit, 2016-2021 (US$ million, AGR %) Figure 172 PPD: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 173 PPD: Regional Market Shares (%), 2021 Figure 174 PPD: Gross Profit, 2016-2021 (US$ million, AGR %) Figure 175 PPD: R&D, 2016-2021 (US$ million, AGR %) Figure 176 Syneos Health: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 177 Syneos Health: Regional Market Shares (%), 2021 Figure 178 Syneos Health: Gross Profit, 2016-2021 (US$ million, AGR %) Figure 179 Wuxi AppTec: Net Revenue, 2016-2021 (US$ million, AGR %) Figure 180 Wuxi AppTec: Regional Market Shares (%), 2021 Figure 181 Wuxi AppTec: Gross Profit, 2016-2020 (US$ million, AGR %)
List of Companies Profiled in the report Charles River Laboratories Clinipace CMIC HOLDING Co., LTD. EPS Corporation ICON plc IQVIA HOLDINGS INC. Labcorp Drug Development MedPace Parexel PPD (Thermofisher Scientific Inc.) Syneos Health Worldwide Clinical Trials Wuxi AppTec
List of Other Companies Mentioned in the report Advanced Accelerator Applications (AAA) Africa Clinical Trial Solutions (ACTS) AKRN Scientific Consulting Althian Clinical Research AnaBios Corporation Ardena Avance Clinical Baxter BioPharma Solutions BenevolentAI BioAgilytix Labs BioDev Services Boehringer Ingelheim Care Access Cerba HealthCare Chemveda Life Sciences ClinChoice Cognate BioServices, Inc. ConcertAI, LLC Cypre, Inc. Deciphex Distributed Bio, Inc. Endocyte Enzymatica ERBC Group Ethica CRO Explora BioLabs Fios Genomics Flamma S.p.A FlowMetric, LLC Frontida BioPharm Immedica Pharma AB JADE Biomedical (JADE) Jubilant Life Sciences Ltd. KCAS Komodo Health Lokavant Lonza Group Matrix Clinical Trials Novartis Optimapharm Ovia Health PathoQuest SAS Recipharm AB Retrogenix Limited RxDataScience SAMDI Tech, Inc. SCIRENT SSS International Clinical Research GmbH StudyKIK SYNthesis med chem Limited Toxikon Corporation Valo Health, Inc. Veeva Systems Vetter Pharma International GmbH Vigene Biosciences, Inc. Viroclinics-DDL Virtonomy Xcell Biosciences, Inc.
List of Associations Mentioned in the Report ASCRO Association of British Pharmaceutical Industry (ABPI) Association of Clinical Research Organizations (ACRO) Central Drugs Standard Control Organization (CDSCO) Department of Health and Family Welfare Development and Reform Commission (NDRC) Development Center For Biotechnology (DCB) European CRO Federation (EUCROF) European Medicines Agency (EMA) Food and Drug Administration (US FDA) ICBio CRO Indian Drug Manufacturer's Association (IDMA) Indian Society for Clinical Research (ISCR) Instituto Brasil de Pesquisa Clnica (IBPClin) Korea Food and Drug Administration (KFDA) Korea Pharmaceutical Manufacturer's Association (KPMA) Medicines and Healthcare Products Regulatory Agency (MHRA) Medicines Manufacturing Industry Partnership (MMIP) Ministry of Health (MOH) Ministry of Health, Labor and Welfare (MHLW) Pharmaceutical and Medical Devices Agency (PMDA) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Contract Research Organisations (CROs) Market Report 2022-2032
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
